Publix Recalls Baby Food Pouches Over Lead Contamination Concerns

The voluntary recall was prompted after routine testing. It is the second such recall recently of baby food over possible lead contamination.One of the nation’s largest supermarket chains has voluntarily recalled pouches of baby food sold in its stores after routine testing found it may be contaminated with lead, according to the company.In a May 9 statement, the supermarket chain, Publix, said that a batch of GreenWise Pear, Kiwi, Spinach & Pea Baby Food it was selling had “the potential to be contaminated with elevated levels of lead.”“As part of our commitment to food safety, potentially impacted products have been removed from all store shelves,” Maria Brous, a Publix representative, said in a statement, adding that no illness had been reported.Publix said the recall was “initiated as a result of routine sampling,” though it was unclear who did the sampling. The maker of the product, Bowman Andros, could not be reached for comment on Sunday. The Food and Drug Administration was notified of the recall.Publix, which operates about 1,400 stores in eight states, did not respond to a request for comment on Sunday.The company did not disclose how many units were affected or whether the recalled product was distributed across all of its stores.The F.D.A. maintains a public database that tracks recalls and safety alerts but it did not have additional information about this recall.Lead exposure can be especially harmful to infants and young children, potentially leading to developmental delays and other long-term health effects, according to the Centers for Disease Control and Prevention.“Lead is extremely harmful to children younger than 6 years, and no safe blood lead level has been identified,” according to the C.D.C. website.This is the second recall in recent months involving baby food and possible lead contamination.In March, Target voluntarily pulled its Good & Gather Baby Pea, Zucchini, Kale & Thyme Vegetable Purée from stores over concerns about elevated lead levels. That recall involved about 25,600 units.“We require our suppliers to comply with all applicable food safety standards and federal, state and local regulations,” a Target representative said in a statement. “This recall involved a limited amount of product, which we took immediate action to remove from our shelves.”Brian Ronholm, director of food policy at Consumer Reports, said on Sunday that awareness of the issue of lead in children’s food had grown in recent years as testing had expanded and cases nationwide increased.He noted that no amount of lead exposure was considered safe for children.“I hope these two incidents are an indicator that the industry is doing a lot more testing in this area than what they were doing before,” Mr. Ronholm said.

Read more →

Surgeons Perform First Human Bladder Transplant

Surgeons in Southern California have performed the first human bladder transplant, introducing a new, potentially life-changing procedure for people with debilitating bladder conditions.The operation was performed earlier this month by a pair of surgeons from the University of California, Los Angeles, and the University of Southern California on a 41-year-old man who had lost much of his bladder capacity from treatments for a rare form of bladder cancer.“I was a ticking time bomb,” the patient, Oscar Larrainzar, said on Thursday during a follow-up appointment with his doctors. “But now I have hope.”The doctors plan to perform bladder transplants in four more patients as part of a clinical trial to get a sense of outcomes like bladder capacity and graft complications before pursuing a larger trial to expand its use.Dr. Inderbir Gill, who performed the surgery along with Dr. Nima Nassiri, called it “the realization of a dream” for treating thousands of patients with crippling pelvic pain, inflammation and recurrent infections.“There is no question: A potential door has been opened for these people that did not exist earlier,” said Dr. Gill, the chairman of the urology department at U.S.C.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Read more →

F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.The Food and Drug Administration on Friday approved the Novavax Covid-19 vaccine, but only for older adults and for others over age 12 who have at least one medical condition that puts them at high risk from Covid.Scientific advisers to the Centers for Disease Control and Prevention, who typically make decisions on who should get approved shots and when, have been debating whether to recommend Covid shots only to the most vulnerable Americans. The F.D.A.’s decision appeared to render at least part of their discussion moot.The new restriction will sharply limit access to the Novavax vaccine for people under 65 who are in good health. It may leave Americans who do not have underlying conditions at risk if a more virulent version of the coronavirus were to emerge. It could also limit options for people who want the vaccine for a wide array of reasons, including to protect a vulnerable loved one.The vaccine had previously been authorized under emergency use. Covid vaccines developed by Pfizer-BioNTech and Moderna, which are more widely used by Americans, were granted full approval in 2022. However, the companies are working on updated shots for the fall, and the new restrictions on the Novavax shot portend a more restrictive approach from the F.D.A.The F.D.A.’s new restrictions also appeared to reflect the high degree of skepticism about vaccines from Robert F. Kennedy Jr., the health secretary, and the other leaders he has appointed at health agencies.“This is incredibly disappointing,” said Dr. Camille Kotton, an infectious disease physician at Massachusetts General Hospital who cares for immunocompromised patients, and a former adviser to the C.D.C.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Read more →

Inside the therapy room: BBC watches as three lives change

19 minutes agoShareSaveNick TriggleShareSaveBBC / Twenty Twenty Productions LtdNicole enters the therapist’s room and clutches what she calls her hugging pillow. She admits to being nervous about sitting down with a stranger to discuss her mental health.She is 31, lives in London and works as chiropractic assistant. She suffers from anxiety when she drives.”There are so many things that so quickly go through my head,” she says. “How far away is it? What is the route? I somehow forget how to drive.”She suffers from panic attacks and her fear of driving means she is constantly cancelling plans.But, over the course of six sessions with psychotherapist Owen O’Kane, it becomes clear her problems are much deeper than just a fear of driving.Digging around in the mindEvery week, one in six of the UK population experience mental health problems such as depression and anxiety and every year more than 1.2 million people seek help from the NHS talking therapies service, with many more paying for support privately.This form of therapy is most commonly used for anxiety and depression, but can also help with a range of other problems, including body image dysmorphia, obsessive compulsive disorder and post traumatic stress disorder. It does not work for everyone: research suggests one-third of people do not benefit.The BBC has followed 12 people, featured in the series Change Your Mind, Change Your Life, who each received six support sessions from therapists. The therapists have used a combination of different talking therapy approaches, including cognitive behavioural therapy which focuses on changing the way we think and behave, alongside other techniques to improve relationships and process trauma.What it reveals is striking: How understanding and learning to manage the mind has the power to transform lives.BBC / Twenty Twenty Productions Ltd”You’re not stuck with the brain you’ve got,” says Owen O’Kane, who has worked in the field for 25 years. He describes his job as like detective work: “People come with what seems to be a reasonable story, but the interesting thing is that very often the story and emotions don’t match. I guess what we are doing is digging around a little bit.” ‘I completely hated myself’Over their sessions, Owen digs deeper into Nicole’s anxiety. At one point she weeps. She admits in the past she has “completely hated” herself. She worries about what people think of her and is socially anxious: “I don’t feel good enough to be there. I might say something wrong. I need people to like me.”Owen questions why she feels like this: “As human beings we like the nice emotions. We like feeling happy, joy, being in love.” but he says some people try to avoid or suppress emotions like fear, dread and sadness, and that can cause anxiety. Instead, he says it is healthier to accept them and accept them as safe. When people get to that point, he says, they start to feel empowered: “They realise they’re not going to be overwhelmed.”Speaking outside the therapy room, Nicole says: “I’m shocked. He got my number straight away. I would see vulnerability as a negative thing, but it’s not.”Asked to describe herself she uses words such as kind, thoughtful, determined and enthusiastic: “I am not a bad person,” she tells Owen.She says she has learned a lot: “Most importantly I found I wasn’t being kind to myself. That was really eye-opening.”Owen says this is typical of many people he treats: “When people get to these crossroads, when they wake up and realise what they are doing, that’s a gold dust moment for me.”‘I had stroke in my early 30s’James likewise learned to think about himself differently thanks to therapy.A 39-year-old father-of-one who works in finance, he struggles with anxiety and, in particular, worries about making mistakes at work. That fear is so debilitating he doesn’t make it to work sometimes.He has been supported by Prof Steve Peters, a psychiatrist who explains perfectionism is at the root of his problems: “If we think it’s the end of the world if we make a mistake, it paralyses you.”James was once an athlete, playing semi-professional football and competing in athletics before specialising in the bobsleigh. He was training for trials for the Great Britain team when he had a stroke eight years ago: “With a flick of a switch, I lost everything,” he says. “It made me feel a lesser man.”Now he fears under-performing at work and losing his job.BBC / Twenty Twenty Productions LtdOver the course of the sessions, Prof Peters explains the key is James’s belief system.First, he gives some seemingly simple advice: “Put your feet on the floor, stand up and walk,” he says. Focusing on the basic task of moving, in James’s case moving so he can get to work, enables someone caught up in catastrophic thinking to block out the negative thoughts that stop them doing something.In later sessions, James and Prof Peters explore what could be behind his problems. James tells Prof Peters about his childhood and how his father would criticise him to push him to improve.Prof Peters explains how James believes that to please you cannot make errors and then the devastating stroke he suffered at a young age has triggered an absolute desire for things to never go wrong again.He tells James he needs to make “peace with himself” by defining himself not by performance but by values and behaviours. He too asks James to describe himself and James replies he is hard-working, honest, engaging, friendly and as someone who would put others first.Over the course of his sessions, James’s way of thinking changes: “I can look at myself in the mirror and feel my value and my worth,” he explains.’My mum died when I was 15’Anjalee’s struggles are somewhat different. They relate to one traumatic event in childhood – her mother died suddenly when she was 15.Now a mother herself, with three children under five, she has struggled emotionally.She has sleepless nights, a tight chest and feels emotionally disconnected. It is worse than any physical pain, says the 34-year-old: “Becoming a mother has reopening everything I’ve tried to suppress.”Her first birth was particularly traumatic. She developed sepsis – the condition her mother died from: “I thought I was not going to survive,” she says. Her psychotherapist, Julia Samuel, explains to Anjalee she has not been able to process what has happened and, as a result, the trauma has stayed with her. When her mother died, Anjalee was in the middle of exams and had two younger siblings, leaving her without time to grieve. BBC / Twenty Twenty Productions LtdJulia suggests eye movement desensitisation and reprocessing therapy, which uses movement to help people process and recover from distressing events.Julia asks Anjalee for her worst memory and she describes how her father tried to save her mother’s life by performing chest compressions in their home until the paramedics arrived. Her mother was rushed out with Anjalee hoping she would return. She never did.Anjalee says she has never talked about this within anyone. Julia asks Anjalee to cross her arms against her chest and start deep breathing and tapping, mimicking a butterfly’s wings flapping. She talks through the memory and how the images in her head are changing to more positive ones.Julia says this type of treatment is particularly effective when dealing with one single traumatic event. One memory, she says, can act as a block on everything.Afterwards, Anjalee speaks about how her symptoms have eased and the contentment she now feels. “My therapist helped me reconnect with the 15-year-old girl I’d silenced. I began to process the trauma that haunted me. I now understand grief as the other side of love.”During May, the BBC is sharing stories and tips on how to support your mental health and wellbeing.Go to bbc.co.uk/mentalwellbeing to find out more.

Read more →

A Ministroke Can Have Major Consequences

So-called transient ischemic attacks can eventually lead to cognitive declines as steep as those following a full-on stroke, new research finds.Kristin Kramer woke up early on a Tuesday morning 10 years ago because one of her dogs needed to go out. Then, a couple of odd things happened.When she tried to call her other dog, “I couldn’t speak,” she said. As she walked downstairs to let them into the yard, “I noticed that my right hand wasn’t working.”But she went back to bed, “which was totally stupid,” said Ms. Kramer, now 54, an office manager in Muncie, Ind. “It didn’t register that something major was happening,” especially because, reawakening an hour later, “I was perfectly fine.”So she “just kind of blew it off” and went to work.It’s a common response to the neurological symptoms that signal a T.I.A., a transient ischemic attack or ministroke. At least 240,000 Americans experience one each year, with the incidence increasing sharply with age.Because the symptoms disappear quickly, usually within minutes, people don’t seek immediate treatment, putting them at high risk for a bigger stroke.Ms. Kramer felt some arm tingling over the next couple of days and saw her doctor, who found nothing alarming on a CT scan. But then she started “jumbling” her words and finally had a relative drive her to an emergency room.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Read more →

Inside the I.V.F. Deliberations at the White House as Key Report Nears

Provide insurance coverage for in vitro fertilization to all members of the U.S. military.Declare I.V.F. to be an “Essential Health Benefit” — and extend coverage to the nearly 50 million Americans insured through the Affordable Care Act.Push Congress to pass a law requiring private insurance companies to cover I.V.F. procedures for any person struggling with infertility.Those are among the sweeping potential policy changes under discussion at the White House as aides prepare to release a highly anticipated report on combating infertility, according to two representatives in the fertility field who participated in the meetings.Infertility doctors and other leaders in the industry, along with representatives of conservative policy groups skeptical of the procedure, have been shuttling in and out of the White House for months to meet with senior officials, including the chief of staff, Susie Wiles. The conversations have been both wide-ranging and highly specific, with aides signaling their interest in a variety of ideas that would make I.V.F. accessible to a far greater swath of the country, some participants said.“They’ve called me over and over again,” said Kaylen Silverberg, a Texas doctor who runs a large fertility clinic in Austin and has been regularly advising the White House group overseeing the report. One of the aides leading the report, he added, called him at 10 o’clock one night last week, presenting a series of hypothetical actions the administration could take to expand I.V.F. access and asking for his input.“She had very, very specific questions: What would the implications be if we did this? What are the pros and cons? What are we missing?” Dr. Silverberg said.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Read more →

‘Love on the Spectrum’ Delivers on the Promise of Reality TV

The Netflix series, which follows a group of autistic people as they search for love in their hometowns, feels good to watch, but don’t just call it feel-good TV.You know the story: A superstar surprises a fan on a talk show, and the online crowd goes wild, sending the clip viral. But when the affable actor Jack Black surprised Tanner Smith on “The Kelly Clarkson Show” in April, a particularly poignant and joyful alchemy was conjured.“Jack! Jack! I’m so excited to finally meet you,” Smith exclaimed as they embrace. “You’re so handsome, you’re looking good, Jack!”“I love you on the show, and I can’t wait for the next season,” Black told Smith, referring to the Netflix reality series “Love on the Spectrum,” which recently wrapped up a memorable third season. “I’m so happy for you for having all of this success,” Black said. “To meet you in person is really amazing for me, too.”Smith is a beloved star in his own right. Online — his handle, tannerwiththe_tism, nods cleverly at his having autism — he has about 2.5 million followers. It’s a number that is not unusual among his castmates, all of whom are autistic.On the viral clip, one commenter called Smith “easily one of the most beautiful humans to walk this earth.” Another wrote, “This was a moment where humanity remembered what love, truth, and presence really looks like.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Read more →

When a Vaccine Safety Trial Becomes Unethical

New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed this way.The Department of Health and Human Services last week announced a new standard for testing the safety of vaccines, a “radical departure from past practices.”All new vaccines will be evaluated against a placebo, an inert look-alike that serves as a point of comparison, the department said. Health Secretary Robert F. Kennedy Jr., as well as many anti-vaccine groups, has long argued that placebo-controlled trials were the only way to fully understand vaccine side effects.To scientists who have spent their careers evaluating vaccines, the plan did not seem so radical. New vaccines are often tested against a placebo in clinical trials. One researcher has created a crowdsourced spreadsheet of more than a hundred examples.But it also concerned vaccine experts that Mr. Kennedy seemed not to recognize the circumstances when placebo groups are neither ethical nor practical. The idea is widely accepted by scientists and enshrined in ethics frameworks for medical research.“He’s asking for something that’s not ethical,” said Arthur Caplan, a leading bioethicist at the New York University Grossman School of Medicine.Why Are Placebos Used in Vaccine Trials?Randomized placebo-controlled trials are often described as the “gold standard” of research: they allow scientists to tease out whether the effects they observe result from the drug itself or some other factor, such as the expectation of treatment.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Read more →

As Congress Debates Cutting Medicaid, a Major Study Shows It Saves Lives

The most extensive research on Medicaid coverage to date found that it reduced the risk of death by 21 percent.The expansion of Medicaid has saved more than 27,000 lives since 2010, according to the most definitive study yet on the program’s health effects.Poor adults who gained Medicaid coverage after the Affordable Care Act expanded access were 21 percent less likely to die during a given year than those not enrolled, the research shows. By analyzing federal records on 37 million Americans, two economists found that deaths fell not only among older enrollees but also among those in their 20s and 30s — a group often assumed to have few medical needs, and who would have been far less likely to qualify for Medicaid before the expansion.The findings were published this month in a National Bureau of Economic Research working paper, as House Republicans were drafting a plan that could significantly cut Medicaid, which covers 71 million low-income or disabled Americans. The House Energy and Commerce Committee, which oversees the program, approved a suite of policies on Wednesday that the Congressional Budget Office estimated would cause millions of people to lose their coverage in the years ahead.The study’s authors said that the publication timing was coincidental — their research has been in progress for two years — but acknowledged that the findings were especially relevant to the current budget discussions.The researchers found that, on average, it costs Medicaid $179,000 to save a year of life — similar to the amounts spent on health care interventions like cervical cancer screenings and leukemia treatment. It is less than the combined public and private spending on interventions like safety inspections for cars or the removal of asbestos from buildings.

Read more →

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.Novo Nordisk will replace its chief executive, Lars Fruergaard Jorgensen, the company announced Friday, citing a sharp decline in its stock price that stemmed from increased competition for its popular weight-loss drug.The Danish drugmaker said it was searching for a new chief executive to soon replace Mr. Jorgensen, who has led Novo Nordisk for eight years.The move reflects a remarkable fall in fortune for the maker of one of the most well-known drugs in the world, which is sold as Ozempic for diabetes and Wegovy for obesity. The company’s stock has fallen by 50 percent in the past year.

.dw-chart-subhed {
line-height: 1;
margin-bottom: 6px;
font-family: nyt-franklin;
color: #121212;
font-size: 15px;
font-weight: 700;
}

Novo Nordisk’s share price
Source: FactSetBy The New York TimesSales of that drug created boom times for Novo Nordisk. In 2023, the company’s extraordinary success prompted the Danish central bank to keep interest rates lower than it otherwise would. For more than a year, Novo Nordisk’s market value surpassed Denmark’s entire gross domestic product.But investors have soured on the company as it has faced increasingly fierce competition. Lower-cost copycat versions of the weight-loss drugs made through a process known as compounding have cut into Novo Nordisk’s sales. Even more damaging has been competition from Eli Lilly, the maker of the drug sold as Mounjaro and Zepbound.Novo Nordisk had a head start, winning approval to market its drug for obesity more than two years before Eli Lilly. But Novo Nordisk has been rapidly losing market share to its competitor: American patients have filled more prescriptions this year for Zepbound than for Wegovy, and the gap has been widening, according to the industry data provider IQVIA.Eli Lilly is also developing new weight-loss drugs, including a daily pill, that are expected to set up years of blockbuster sales for the company. Novo Nordisk has a hazier path forward.

Read more →